Provided by Tiger Fintech (Singapore) Pte. Ltd.

MAIA Biotechnology Inc.

2.00
-0.1000-4.76%
Post-market: 1.97-0.0300-1.50%19:44 EDT
Volume:209.58K
Turnover:414.43K
Market Cap:59.17M
PE:-1.91
High:2.04
Open:2.02
Low:1.90
Close:2.10
Loading ...
Aug 08, 2023

Major Issues Report

Form 8-K - Current report
Aug 08, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 12, 2023

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Jul 11, 2023

Major Issues Report

Form 8-K - Current report
Jul 10, 2023

Major Issues Report

Form 8-K - Current report
Jul 01, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jun 20, 2023

Major Issues Report

Form 8-K - Current report
Jun 09, 2023

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Jun 09, 2023

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
May 30, 2023

Major Issues Report

Form 8-K - Current report
May 08, 2023

Major Issues Report

8-K - Current report
May 08, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 27, 2023

Major Issues Report

8-K - Current report
Apr 21, 2023

Correspondence

Form CORRESP - Correspondence
Apr 21, 2023

Correspondence

Form CORRESP - Correspondence
Apr 21, 2023

Correspondence

Form CORRESP - Correspondence
Apr 21, 2023

Correspondence

Form CORRESP - Correspondence
Apr 21, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Apr 20, 2023

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Apr 20, 2023

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses